Biography: Hyper Aadi is an Indian film actor, who has worked predominantly in the Telugu movie industry.

Fresh off a pivot from commercial pharma business to preclinical biotech, Aadi Bioscience has rebranded to better match its strategic reboot. The company will henceforth be known as Whitehawk ...

Full Year Net Loss: $63.7 million, compared to $65.8 million in prior year. Aadi Bioscience Inc (NASDAQ:AADI) has successfully transitioned into Whitehawk Therapeutics, focusing on advanced ADC ...

Aadi Industries Ltd., incorporated in the year 1994, is a Small Cap company (having a market cap of Rs 5.99 Crore) operating in Miscellaneous sector. Aadi Industries Ltd. key Products/Revenue Segments ...

("Aadi Sub") to Kaken Pharmaceuticals ("Kaken") for a cash payment of $100 million plus certain customary adjustments, completing the strategic transformation first announced in December 2024 ...

Stay updated on market trends for AADI. Aadi Bioscience secures ADC portfolio license, involving $44 million upfront and $805 million in milestones plus royalties.

including the pending sale of Aadi Sub to Kaken and the payment of the upfront and early milestones under the Wuxi ADC agreement; the anticipated timing of the Company's development of its ...

Aadi is a precision oncology company with a vision to make bold choices in applying technology to efficiently deliver improved precision oncology therapies for people living with difficult-to-treat ...